5,5'-difluoro-3,3'-diindolyl(4-methylphenyl)methane | 1189117-63-2

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: 5,5'-difluoro-3,3'-diindolyl(4-methylphenyl)methane
• 英文别名: 5-fluoro-3-[(5-fluoro-1H-indol-3-yl)-(4-methylphenyl)methyl]-1H-indole
• CAS: 1189117-63-2
• 化学式: C₂₄H₁₈F₂N₂
• 分子量: 372.417
• InChiKey: SDHNORLJWGHVPA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.1
• 重原子数：
  28
• 可旋转键数：
  3
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  31.6
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  5-氟吲哚 、 对甲基苯甲醛 在 硫酸 作用下， 以 水 为溶剂， 以52%的产率得到5,5'-difluoro-3,3'-diindolyl(4-methylphenyl)methane
  参考文献：
  名称：

  Novel 3,3′-diindolylmethane derivatives: Synthesis and cytotoxicity, structural characterization in solid state

  摘要：

  A series of 3,3'-dindolylmethane derivatives have been synthesized and their structures were characterized in solid state by C-13 CP/MAS NMR and two of them by X-ray diffraction measurements. They exhibited well expressed cytotoxicity against human melanoma cell lines. Derivatives bearing fluoro, bromo, iodo, and nitro substituents in indole or benzene rings caused 50% inhibition of the viability of ME18 and ME18/R cell lines at concentration ranging 9.7-17.3 mu M. (C) 2009 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2009.05.011

文献信息

• Novel 3,3′-diindolylmethane derivatives: Synthesis and cytotoxicity, structural characterization in solid state
  作者：Dorota Maciejewska、Magdalena Rasztawicka、Irena Wolska、Elżbieta Anuszewska、Beata Gruber

  DOI：10.1016/j.ejmech.2009.05.011

  日期：2009.10

  A series of 3,3'-dindolylmethane derivatives have been synthesized and their structures were characterized in solid state by C-13 CP/MAS NMR and two of them by X-ray diffraction measurements. They exhibited well expressed cytotoxicity against human melanoma cell lines. Derivatives bearing fluoro, bromo, iodo, and nitro substituents in indole or benzene rings caused 50% inhibition of the viability of ME18 and ME18/R cell lines at concentration ranging 9.7-17.3 mu M. (C) 2009 Elsevier Masson SAS. All rights reserved.